Literature DB >> 1629568

Changes in superoxide dismutase activity in the gastric mucosa of peptic ulcer patients.

Y Naito1, T Yoshikawa, T Ando, A Kishi, S Ueda, H Oyamada, M Kondo.   

Abstract

A highly sensitive chemiluminescence method for determining superoxide dismutase (SOD) activities in human gastric mucosa obtained by endoscopic biopsy is described. As the chemiluminescence probe, we used Cypridina luciferin analogue (CLA), a very sensitive and specific probe to detect superoxide generated from hypoxanthine-xanthine oxidase system. SOD activity in the gastric mucosa was assayed by the inhibition of CLA-dependent chemiluminescence in highly diluted tissue homogenates. SOD activity was distributed throughout the gastric mucosa. The marginal mucosa of peptic ulcers showed significantly lower SOD activity when the ulcer was in the active stage, and during the healing stage showed high activity when compared to the endoscopically normal adjacent mucosa of the same patients. The preliminary data suggest that enzymatic SOD in the gastric mucosa may play an important role in the pathogenic and healing processes of human peptic ulcers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629568     DOI: 10.1097/00004836-199206001-00023

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  13 in total

1.  Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils.

Authors:  Kazushi Sakurai; Toshihiro Osaka; Katsuya Yamasaki
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

2.  Cold restraint stress-induced gastric mucosal dysfunction. Role of nitric oxide.

Authors:  T Coskun; B C Yeğen; I Alican; O Peker; H Kurtel
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

3.  Gastric mucosal superoxide dismutases in Helicobacter pylori infection.

Authors:  J M Götz; C I van Kan; H W Verspaget; I Biemond; C B Lamers; R A Veenendaal
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

4.  Impairment of intestinal mucosal antioxidant defense system during Salmonella typhimurium infection.

Authors:  A Mehta; S Singh; N K Ganguly
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

5.  Dynamics of Oxidative Stress in Helicobacter pylori-Positive Patients with Atrophic Body Gastritis and Various Stages of Gastric Cancer.

Authors:  Vladislav Vladimirovich Tsukanov; Olga Valentinovna Smirnova; Edward Vilyamovich Kasparov; Alexander Alexandrovich Sinyakov; Alexander Viktorovich Vasyutin; Julia Leongardovna Tonkikh; Mikhail Alexandrovich Cherepnin
Journal:  Diagnostics (Basel)       Date:  2022-05-11

6.  Cellular mucosal defense is attenuated with chronicity of Helicobacter pylori infection.

Authors:  Geoffrey M Matthews; David Tivey; Adrian G Cummins; Ross N Butler
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

7.  Effects of FK506, an immunosuppressive agent, on genesis of water-immersion stress-induced gastric lesions in rats.

Authors:  E Hamajima; S Sugiyama; H Hoshino; H Goto; Y Tsukamoto; T Ozawa
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

Review 8.  Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.

Authors:  Asima Bhattacharyya; Ranajoy Chattopadhyay; Sankar Mitra; Sheila E Crowe
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

Review 9.  Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies.

Authors:  Tian Tian; Ziling Wang; Jinhua Zhang
Journal:  Oxid Med Cell Longev       Date:  2017-06-28       Impact factor: 6.543

10.  AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice.

Authors:  Hubert Zatorski; Maciej Salaga; Marta Zielińska; Kinga Majchrzak; Agata Binienda; Radzisław Kordek; Ewa Małecka-Panas; Jakub Fichna
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.